- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/557 - Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
Patent holdings for IPC class C07D 239/557
Total number of patents in this class: 97
10-year publication summary
|
10
|
3
|
6
|
1
|
4
|
3
|
5
|
7
|
7
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4764 |
7 |
| The Salk Institute for Biological Studies | 447 |
4 |
| Sanford Burnham Prebys Medical Discovery Institute | 308 |
4 |
| Yale University | 2562 |
4 |
| Bayer Pharma AG | 1009 |
3 |
| R.J. Reynolds Tobacco Company | 504 |
3 |
| Boehringer Ingelheim International GmbH | 4485 |
2 |
| Bayer Cropscience AG | 1836 |
2 |
| Regents of the University of Minnesota | 2797 |
2 |
| University of Georgia Research Foundation, Inc. | 1081 |
2 |
| Grindeks, a Joint Stock Company | 41 |
2 |
| Center for Intelligent Research in Crystal Engineering, S.L. | 21 |
2 |
| Irccs Neuromed S.p.A. | 2 |
2 |
| Istituto Pasteur Italia | 2 |
2 |
| Thirtyfivebio Limited | 7 |
2 |
| F. Hoffmann-La Roche AG | 7800 |
1 |
| The Regents of the University of California | 20842 |
1 |
| Genentech, Inc. | 4119 |
1 |
| AstraZeneca AB | 2824 |
1 |
| AstraZeneca UK Limited | 522 |
1 |
| Other owners | 49 |